Item 1A. Risk Factors.
3K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors.
There have been no material changes in the risk factors from those discussed in Item 1A, Risk Factors included in our Annual Report on Form 10-K for the year ended December 31, 2021.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
(c) Share Repurchases
| ISSUER PURCHASES OF EQUITY SECURITIES | |||||||||||||||||||||||
| 2022 Calendar Month | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Maximum Number of Shares That May Yet be Purchased Under the Plans or Programs | |||||||||||||||||||
| April | 3,486 | $ | 112.36 | 1,770,572 | 23,229,428 | ||||||||||||||||||
| May - prior authorization | 2,529 | 109.01 | 1,773,101 | — | |||||||||||||||||||
| May - current authorization | — | — | — | 25,000,000 | |||||||||||||||||||
| June | 1,169 | 117.42 | 1,169 | 24,998,831 | |||||||||||||||||||
| Total | 7,184 | $ | 112.00 |
In May 2022, the Board of Directors approved an authorization for the Company to repurchase up to 25 million of its common shares. This authorization, which does not have an expiration date, terminated the 23,226,899 shares that remained under the Board’s May 2021 authorization to repurchase 25 million shares.
Share repurchases under this authorization may be accomplished through open market purchases, including trading plans entered into with one or more brokerage firms in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, through privately negotiated transactions, pursuant to our equity incentive awards, or otherwise. During the second quarter 2022, all repurchases were accomplished in conjunction with our equity incentive awards at the then-current market prices; there were no open market purchases during the quarter.
Progressive’s financial policies state that we will repurchase shares to neutralize dilution from equity-based compensation in the year of issuance and as an option to effectively use under leveraged capital.
Previous: Item 4. Controls and Procedures. · Next: Item 5. Other Information.